SYNB Price Prediction, Putnam BioRevolution ETF AI Recommendations

The most notable companies in this group are NVIDIA Corp (NASDAQ:NVDA), Alphabet (NASDAQ:GOOGL), Eli Lilly & Co (NYSE:LLY), ABBVIE (NYSE:ABBV), AstraZeneca PLC (NASDAQ:AZN), Regeneron Pharmaceuticals (NASDAQ:REGN), ZOETIS (NYSE:ZTS), lululemon athletica (NASDAQ:LULU), DuPont de Nemours (NYSE:DD), Biogen (NASDAQ:BIIB).

The investment seeks long term capital appreciation. The fund invests mainly in common stocks (growth or value stocks or both) of companies worldwide of any size with a focus on “biology revolution” companies. From time to time, the fund may invest a significant portion of its assets in companies in one or more related industries or sectors, including the health care, consumer discretionary, consumer staples, biotechnology and materials sectors. The fund is non-diversified.

The average market capitalization across the Putnam BioRevolution ETF ETF is 220.64B. The market cap for tickers in the group ranges from 445.16M to 2.85T. NVDA holds the highest valuation in this group at 2.85T. The lowest valued company is DNA at 445.16M.

The average weekly price growth across all stocks in the Putnam BioRevolution ETF ETF was 1%. For the same ETF, the average monthly price growth was 1%, and the average quarterly price growth was 6%. ASND experienced the highest price growth at 27%, while LNZA experienced the biggest fall at -5%.

The average weekly volume growth across all stocks in the Putnam BioRevolution ETF ETF was -27%. For the same stocks of the ETF, the average monthly volume growth was 2% and the average quarterly volume growth was -44%